EP0050146A4 - Dispositif de fractionnement du sang. - Google Patents

Dispositif de fractionnement du sang.

Info

Publication number
EP0050146A4
EP0050146A4 EP19810901222 EP81901222A EP0050146A4 EP 0050146 A4 EP0050146 A4 EP 0050146A4 EP 19810901222 EP19810901222 EP 19810901222 EP 81901222 A EP81901222 A EP 81901222A EP 0050146 A4 EP0050146 A4 EP 0050146A4
Authority
EP
European Patent Office
Prior art keywords
blood
signal
mode
pump
output
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19810901222
Other languages
German (de)
English (en)
Other versions
EP0050146A1 (fr
Inventor
Arnold A Bilstad
Richard I Brown
John T Foley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Publication of EP0050146A1 publication Critical patent/EP0050146A1/fr
Publication of EP0050146A4 publication Critical patent/EP0050146A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496Plasmapheresis; Leucopheresis; Lymphopheresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3601Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit
    • A61M1/3603Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit in the same direction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/08Supports for equipment
    • A61M2209/082Mounting brackets, arm supports for equipment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/08Supports for equipment
    • A61M2209/084Supporting bases, stands for equipment

Definitions

  • blood fractionation includes the separation and/or treatment of any fraction of whole blood, including but not limited to plasma, red cells, white cells, platelets and cryoprecipitate.
  • Typical blood fractionation techniques utilize the collection of whole blood from donors in bags, and removal of the bags to a centrifuge where the blood fraction is separated from the whole blood. The blood fraction is withdrawn from the bag and the re ⁇ maining blood is returned to the donor.
  • plasma One significant blood fraction which has been withdrawn by centrifugation for many years is plasma.
  • plasmapheresis techniques a bag containing whole blood is placed in a centrifuge where the plasma is separated and the remaining blood is returned to the donor.
  • a membrane plasmapheresis apparatus in which a relatively inexpensive, disposable plasmapheresis filter membrane cell is utilized, is disclosed in DeVries, et al. U.S. patent application Serial No. 942,077, filed September 13, 1978.
  • Another membrane plasmapheresis filter cell of the disposable type is disclosed in DeVries, et al. U.S. patent application
  • a still further object of the present invention is to provide blood fractionation apparatus which is relatively simple in construction and efficient to manufacture.
  • Another object of the present invention is to provide blood fractionation apparatus which is ex- tremely safe and reliable to use, and which includes means for preventing incorrect operation thereof.
  • Another object of the present invention is to provide blood fractionation apparatus which includes a fail-safe circuit and safety devices for preventing the apparatus from operating improperly.
  • a further object .of the present invention is to provide an apparatus that is especially suited for continuous blood fractionation, in which the blood is withdrawn from a donor or' patient, and the fraction is removed while the remainder of the blood is con ⁇ tinuously returned to the donor or patient.
  • Another object of the present invention is to provide blood fractionation apparatus which includes memory means operative to prevent incorrect actuation of the apparatus.
  • a further object of the present invention is to provide blood fractionation apparatus which can be easily operated by a physician or nurse and which displays appropriate information to the operator.
  • blood fractionation apparatus which comprises a main housing carrying at least one blood pump, a cell housing for receiving a disposable blood fractionation filter membrane cell, electrical control apparatus and means for coupling the housing to a source of electric current.
  • the main housing has a. panel defining a plurality of slots for receiving disposable blood flow tubing within predetermined slots.
  • the housing carries an occluded vein sensor and a bubble detector for cooperating with the tubing.
  • Pressure sensing means is provided for sensing pressure adjacent the disposable cell.
  • the housing has a manually operable mode switch for setting control functions of the ap ⁇ paratus.
  • programmed means are provided for preventing incorrect actuation of predeter- mined control functions.
  • a door member covers at least a portion of the slots to prevent access thereto. Means inhibit operation of the door member and thus access to the slots unless the manually operable mode switch is in a predetermined position.
  • the housing carries a safety clamp for clamping the tubing to restrict flow therein.
  • Control means are coupled to the safety clamp and to the pump for inhibiting operation of the pump when the tubing is clamped.
  • Audible alarm means are ⁇ ro- vided for signaling a selected malfunction.
  • Operator con ⁇ trol means are provided for muting the alarm, with the alarm means being operable to enable predetermined func ⁇ tions during selected modes while other functions are in ⁇ hibited.
  • the apparatus of the illustrative embodiment also includes an anticoagulant pump and means for carrying a supply of anticoagulant. The presence of anticoagulant is sensed and operation of the pump is inhibited if no anticoagulant is sensed.
  • the apparatus of the illustrative embodiment includes a fail-safe circuit coupled to the safety clamp, bubble detector and pump.
  • the fail-safe circuit includes delay means and means for terminating operation of the apparatus in response to a predetermined signal from either the safety clamp, bubble detector or pump, after a predeter ⁇ mined delay from receipt of the predetermined signal.
  • the electrical con ⁇ trol apparatus is operable to set control functions of the apparatus.
  • the control functions comprise a plurality of operational modes and the electrical control apparatus includes means for providing a signal representing each mode, means for encoding the mode signals to output a highest priority signal only, a comparator, programmed memory means for storing proper mode sequence data, means for feeding the encoded mode signal to an input of the programmed memory means, means for feeding the encoded mode signal to-the comparator, and means for feeding the memory means output to the comparator.
  • the comparator is operable to compare the encoded mode signal with the memory means output.
  • Means are coupled to the output of the comparator for providing (a) a first signal if there is a first relationship between the encoded mode signal and the memory means output, and (b) a second signal if there is a second relationship between the encoded mode signal and the memory means output.
  • control functions include a load mode enabling the fractionation apparatus to be loaded with disposable tubing, a prime mode for priming the system with a selected liquid, a bypass mode for withdrawing who.le blood from a donor and passing the whole blood through the membrane cell but returning all blood components to the donor, and a collect mode for collecting one of the separated components while re- turning other blood components to the donor.
  • the control f nctions aJso include an irrigate mode in which the ap ⁇ paratus is not functioning to collect one of the separated components, but a selected solution is provided to main ⁇ tain venal punctures open and the tubing clean.
  • the control functions further include a reinfuse mode in which the other blood components within the tubing are reinfused to the donor after one of the separated com ⁇ ponents is collected.
  • the blood fractiona- tion apparatus includes a whole blood pump, a recircula- tion pump, speed control means coupled to the whole blood pump and recirculation pump, blood flow tubing, means for sensing (a) the whole blood pump rate, (b) the recircula ⁇ tion pump rate, (c) blood pressure, (d) amount of blood component that is collected, (e) air bubbles in the tubing and (f) hemolysis.
  • Display means are provided for dis ⁇ playing predetermined control functions and an alarm cir ⁇ cuit is present for providing an audible alarm resulting from the sensing ⁇ of predetermined conditions.
  • Safety clamping means are provided for clamping the tubing under predetermined conditions.
  • a fail-safe circuit is coupled to the safety clamping means, air bubble sensing means and pumps.
  • the fail-safe circuit includes delay means and means for terminating operation of the apparatus in re- sponse to a predetermined signal from either the clamping means, air bubble sensing means or pumps, after a predeter ⁇ mined delay from receipt of the predetermined signal.
  • FIGURE 1 is a perspective view of blood fractiona ⁇ tion apparatus constructed in accordance with the prin ⁇ ciples of the present invention
  • FIGURE 2 is a front view of the top panel thereof;
  • FIGURE 3 is a top view of the shelf thereof
  • FIGURE 4 is a view of the plasma collection scale thereof
  • FIGURE 5 is a perspective view of the occluded vein sensor carried by the apparatus of FIGURE 1;
  • FIGURE 6 is an enlarged fragmentary view of the manually operable mode switch carried by the apparatus of FIGURE 1, with the door in its closed position;
  • FIGURE 7 is a view similar to the view of FIGURE 6, with the door in its open position;
  • FIGURE 8 is a fragmentary view of another portion of the panel of the FIGURE 1 apparatus
  • FIGURE 9 is a fragmentary view of another portion of the front panel of the apparatus of FIGURE 1;
  • FIGURE 10a_, 10b and 10c_, when connected together, comprise a block diagram of the elements and circuitry of blood fractionation apparatus constructed in ac ⁇ cordance with the principles of the present invention;
  • FIGURE ll and lib when connected together, comprise a schematic circuit diagram of the mode circuit of blood fractionation apparatus constructed in accordance with the principles of the present invention
  • FIGURE 12 is a schematic circuit diagram of the pump start circuit apparatus constructed in accordance with the principles of the present invention.
  • FIGURE 13 is a schematic circuit diagram of the alarm mute circuit of apparatus constructed in ac ⁇ cordance with the principles of the present invention
  • FIGURE 14 is a schematic circuit diagram of the pump control circuit constructed in accordance with the principles of the present invention
  • FIGURE 15 is a schematic circuit diagram of the alarm circuit of apparatus constructed in accordance with the principles of the present invention.
  • FIGURE 16 is a schematic circuit diagram of the clamp circuit of apparatus constructed in accordance with the principles of the present invention
  • FIGURE 17 is a schematic circuit diagram of the fail-safe circuit of blood fractionation apparatus con ⁇ structed in accordance with the principles of the present invention.
  • FIGURE 18 is a schematic circuit diagram of the basic fail-safe power system of blood fractionation apparatus constructed in accordance with the principles of the present invention.
  • a main housing 30 is carried by an upright 32 which is generally L-shaped and includes a base 34 to which casters 36 are connected.
  • a series of ladder rungs 38 are provided to enable housing 30 to be moved vertically as desired for proper height positioning, and a handle 40 is provided for enabling the housing 30 and base 34 to be moved along the floor.
  • Housing 30 includes a front panel 42 and a shelf 44, with front panel 42 carrying display windows and control switches, racks 46 for receiving disposable blood flow tubing, a manually operable mode switch 48 for setting control functions of the apparatus, and a cell housing 49 for receiving a disposable blood frac ⁇ tionation filter membrane cell.
  • Panel 42 also carries a tubing clamp 50, a hemolysis detector 52 and a bubble detector 54.
  • Tubing clamp 50, hemolysis detector 52 and bubble detector 54 are con ⁇ nected to cooperate with the disposable tubing that is carried by rack 46.
  • the display-windows preferably allow the visi ⁇ bility of light emitting diodes which indicate various conditions.
  • the status of the apparatus is displayed at window 56
  • the various alarms or mal ⁇ functions are displayed at window 58
  • the whole blood pump rate is displayed at window 60
  • the recirculation pump rate is displayed at window 62
  • the plasma collec- tion volume is displayed at window 64
  • the membrane pressure is displayed at window 66.
  • Panel 42 carries a main off/on switch 68, an end point switch 69, a pump start switch in the form of a push button 70, an emergency stop switch 71, mute alarm switch in the form of a push button 72 for. muting the alarm sound, a sensor override switch 74 in the form of a push button for overriding a particular sensor that is in an alarm con- dition and a reset switch 76 in the form of a push button.
  • the shelf 44 supports blood pump 78 and recircula- tion pump 80. Pumps 78 and 80 are peristaltic pumps, with their motors being enclosed within the housing 30. Shelf 44 also supports an occluded vein sensor 82 and a writing surface 84. While in the illustrative embodi ⁇ ment the anticoagulant pump is not carried by the housing, if desired, the anticoagulant pump could be held on an upright pole 86 and powered by means of an auxiliary power receptacle.
  • Upright pole 86 is connected to the housing 30 for supporting a plasma collection scale 88 and an anti ⁇ coagulant liquid detector 87.
  • Plasma collection scale 88 includes a hook 89 for receiving a plasma collection container, preferably in the form of a plastic bag de ⁇ fining a hole for being received by hook 89.
  • Cell housing 49 encloses a membrane cell 90, as illustrated in FIGURE 2.
  • Cell 90 may comprise a disposable plasmapheresis membrane cell as described in De Vries, et al. U.S. patent application Serial No. 942,077, filed September 13, 1978 or a disposable cell as described in De Vries, et al. U.S. patent application Serial No. 971,905, filed December 21, 1978.
  • port 100 is the whole blood inlet and port 102 is the red cells outlet.
  • Port 104 is the plasma outlet.
  • a Y-site 106 is provided and is coupled to the needle which is connected to the donor's vein for the withdrawal of whole blood.
  • a Y-site inlet 107 is coupled to the anticoagulant supply and the Y-site outlet 108 is connected to whole blood tubing 110.
  • Whole blood tubing 110 is coupled through occluded vein sensor 82 and it extends through pump 78, and to a Y-site 112. From the Y-site, the whole blood travels through .tubing 114 to whole blood inlet 100 and also through tubing 116 to a pressure reservoir 118.
  • a pressure transducer is connected to pressure reservoir 118 for measuring the pressure with respect to whole blood flow line 116.
  • a sterile barrier 120 is provided between the pressure reservoir 118 and the pressure transducer.
  • a blood outlet line 122 is coupled to red cell outlet 102 and the red cells flow via line 122 through bubble trap 124 and tubing clamp 50 and to a Y-site 125 below clamp 50.
  • .Recirculation tubing 126 is coupled to one of the arms of the Y so that the red blood cells will flow via tubing 126, through pump 80 and for recirculation via tubing 114 into blood inlet 100.
  • the other arm of Y-site 125 is coupled to tubing 128 so that some of the red cells will flow via tubing 128 to another Y-site 130 and then via tubing 132 back to the donor.
  • a saline line 134 is con ⁇ nected to the other arm of the Y-site 130 for providing saline to the dolior.
  • a saline line 136 is also coupled to occluded vein sensor 82 for priming the system and for maintaining patency of the needle.
  • Tubing 138 is connected to plasma outlet 104 and the plasma -will flow via tubing 138 and through an optical density chamber 139 and then tubing 141 to the plasma collection bag 143.
  • a Y-site 145 is pro ⁇ vided at the outlet of optical density chamber 139 with one arm of the Y being coupled to tubing 141 and the other arm of the Y being coupled to a bypass line 147.
  • Bypass line 147 returns the plasma to the bubble trap 124.
  • the purpose of the bypass -line is that during start-up, a substantial amount of saline is found mixed with the plasma. This is detected by the hemolysis detector 52 and the plasma mixed with saline will flow in the bypass line 147 until line
  • the hemolysis detector 52 will sense the relatively clear plasma and the "collect plasma” lamp will be energized to indicate to the operator that rotary mode switch 48 can be turned to the "collect” mode.
  • Hemolysis detector 52 may be constructed in accordance with the disclosure in a patent applica ⁇ tion entitled, "Photometric Apparatus and Method", naming Richard I. Brown, Arnold C. Bilstad and
  • Bubble detector 54 may be con ⁇ structed in accordance with the disclosure of a U.S. patent application entitled “Liquid Absence Detector”, naming as inventors Arnold C. Bilstad and Michael
  • Occluded vein sensor 82 may be constructed in ac ⁇ cordance with the disclosure of a U.S. patent applica ⁇ tion entitled, "Liquid Flow Sensing Apparatus", naming Richard I. Brown as inventor. Serial No. 127,554, and filed March 6, 1980.
  • -The plasma scale used in connection with plasma chamber 88 may be .constructed in accordance with the disclosure of a U.S. patent application entitled, "Apparatus and Method For Weighing Material Being Collected", naming Arnold C. Bilstad and John T. Foley as inventors, Serial No. 127,734, and filed March 6, 1980.
  • the mode switch 48 may be constructed in accordance with the dis ⁇ closure of the U.S. patent application entitled. "Control System For Fluid Flow Apparatus", naming Arnold C. Bilstad and Richard I. Brown as inventors. Serial No. 139,884, and filed on the same day as the present application.
  • Cell housing 49 may be con- structed in accordance with the disclosure of a U.S. patent application entitled, "Method and Apparatus For Obtaining a Desired Rate of Plasma Collection From a Membrane Plasmapheresis Filter”, naming Richard I, Brown and Arnold C. Bilstad as inventors, Serial No. 127,733, and filed on March 6, 1980.
  • Anticoagulant detector 87 may be constructed in accordance with the disclosure of a United States patent application en ⁇ titled, "Liquid Presence Detector", naming Arnold C. Bilstad and Richard I. Brown as inventors, Serial No. 127,553, filed March 6, 1980.
  • mode switch 48 is rotated to "load” position and door 100, on which the mode switch 48 is carried, is opened from its closed position as illustrated in ⁇ FIGURE 6 to its open positions as il ⁇ lustrated in FIGURE 7. It can be seen that door 140 is hinged at 142. The disposable tubing and equip ⁇ ment are then inserted into the slots of the slotted racks 46 as illustrated in FIGURES 2 and 7-9. Once all of the disposable lines are properly connected and inserted into the slotted racks 46 as described above, door 100 is closed and "on" switch 68 is turned to its "on” position.
  • the end point switch 69 is actuated to set the predetermined amount to be col ⁇ lected.
  • the whole blood pump speed is set by means of dial 144 and the recirculation pump speed is set by means of dial 146 (FIGURES 1 and 2) .
  • the dial switch 48 is turned to "prime” position and the system is primed. After priming the system, the lines 110 and 132 are coupled to the donor and the procedure may then commence.
  • Dial switch 48 is turned to its "bypass” position. In this position, the donor's blood is withdrawn via tubing 110, passed through membrane cell 90, and both the red blood cells and the plasma are returned to the donor instead of the plasma being collected. In this manner, the priming solution (e.g., saline solution) is flushed out of the system and not collected.
  • the priming solution e.g., saline solution
  • status display 56 displays "collect plasma” and the operator may then turn dial switch 48 to its "collect” position.
  • the plasma filtrate from membrane cell 90 is transferred via line 138, chamber 139 and line 141 to the plasma collection container 143 that hands from hook 89 while the red cells are returned to the donor via lines 122, 128 and 132.
  • Dial switch 48 is manually operated and carries an electrical switch which follows the mechanical turning of the dial switch.
  • the system is programmed so that the operation will terminate if the dial switch is turned improperly, such as in the wrong direction or from one mode to the wrong mode. For example, if the dial switch is incorrectly turned from "bypass" to "prime", the status display will show “mode switch” and shortly thereafter the system will shut off. Any other incorrect turning of the dial switch will cause the "mode switch” readout to occur on display 56 and shortly thereafter the system will turn off.
  • dial switch 48 In the event that the dial switch 48 is not in one of the discrete positions, but is between positions, display 56 shows "mode switch” but there is a delay preventing the system from being turned off so that the operator has time to move from one position on dial switch 48 to another position of the dial switch. Door 140 cannot be opened unless dial switch 48 is in its "load” position.
  • FIGURE 7 at the back of dial switch 48 there is a keyway 150 which fits on a key 152. When dial switch 48 is turned, keyway 150 also turns key 152 which is coupled to various camming members that appropriately clamp the tubing that is within the housing.
  • a detailed description of switch 48 is set forth in Bilstad and Brown U.S. application for "Control System For Fluid Flow Apparatus", Serial No.
  • Tubing clamp 50 comprises a pair of magnetically coupled levers which must be squeezed together to unclamp the tubing. Once the tubing is undamped, pump start button 70 may be pressed and the pumps will start slowly at first and then increase speed automatically.
  • the two levers which form the clamp and which are pushed together to unclamp the tubing are coupled together by means of an electromagnet. If for some reason the two levers are forced apart or the electro ⁇ magnet fails so that they come apart, the tubing clamp will clamp the tubing and the pumps will immediately stop, as the system is programmed to prevent operation of the pumps while the tubing is being clamped.
  • status display 56 shows "return clamped” and when "return clamped” is displayed, the pumps cannot oper- ate. It can be seen that the machine is manually operated and under the control of the operator. In order for the machine to operate, the operator must perform certain positive actions.
  • the rotary switch 48 can be turned to "irrigate". In the "irrigate” mode, the machine is shut down and there is no plasma collection, but the saline is dripping to keep the venapunctures open and the lines clear.
  • the "reinfuse” mode may be used after the plasma is collected. After collection, the rotary switch 48 can be turned to "reinfuse” and the system is switched so that saline is pumped from the saline bottle through
  • the plasma container is removed from hook 89 and another collection via the machine can be performed.
  • the system is programmed so that inadvertent turning of the rotary switch can be overridden.
  • FIGURES 10a-10b-l ⁇ £ A block diagram of the basic system is set forth in FIGURES 10a-10b-l ⁇ £, when these Figures are connected 0 together.
  • the various sensors or detectors are shown on the left side of the diagram and include a whole blood pump tachometer 160, a recirculation pump tachometer 162, a membrane pressure sensor 164 which is connected at the hlood inlet side with respect 5 to membrane cell 90, a plasma strain gauge 166 for weighing the collected plasma and forms a part of scale 88, an ACD presence sensor " 87, bubble detector sensor 54, occluded vein sensor 82, and hemodetector sensor 52.
  • Whole blood pump tachometer 160 is coupled to whole blood sensor circuit 170 via line 171 and circuit 170 is coupled to whole blood pump rate and volume display 60 via line 172. Tachometer 160 is also coupled to fail-safe circuit 174 via lines 171 and 175 and an emergency stop switch 173 is also coupled to fail-safe circuit 174.
  • Recirculation pump tachometer 162 is coupled to recirculation pump circuit 176 via line 177 and to fail-safe circuit 174 via lines 177 and 178.
  • Recircu ⁇ lation pump circuit 176 is coupled to recirculation pump rate display 62 via line 179.
  • Membrane pressure sensor 164 is coupled to membrane pressure preamplifier 180 which is coupled to membrane pressure circuit 182 via line 183.
  • Cir ⁇ cuit 182 is coupled to membrane pressure display 66 via line 184.
  • Plasma strain gauge 166 is coupled to plasma scale preamplifier 186 via line 187.
  • Preamplifier 186 is coupled to a plasma scale circuit 188 via line 189.
  • Circuit 18 * 8 is coupled to plasma volume display 64 via line 190.
  • ACD sensor 87 is coupled to an ACD detector preamplifier 192 via line 193.
  • Preamplifier 192 is coupled to the plasma scale preamplifier via line 194.
  • Line 189 couples the output of the plasma scale preamplifier 186 to an ACD detector circuit 196, the output 198 of which is connected to alarm circuit 200.
  • Fail-safe circuit 174 is also connected to alarm circuit via line 202.
  • the output of membrane pressure circuit 182 is also connected to alarm circuit 200 via line 204.
  • the output of alarm circuit 200 is connected via line 205 to alarm display 58.
  • Alarm display 58 has the capacity to show the following readout if a malfunction with respect to one of the following items occur: “bubble detector”, “occluded vein”, “hemolysis detector”, “membrane pressure”, “ACD empty” and “fail-safe”.
  • Bubble detector sensor 54 is coupled to bubble detector circuit 206 via line 207.
  • the output of bubble detector circuit 206 is coupled via line 208 to fail-safe circuit 174 and another output of bubble detector circuit 206 is coupled via line 209 to alarm circuit 200.
  • Occluded vein sensor 82 is coupled to alarm circuit 200 via line 210.
  • Hemodetector sensor 52 is coupled to hemodetector circuit 212 via line 213, with the output of hemodetector circuit 212 being coupled to alarm circuit 200 via line 214.
  • Sensor override switch 74 is coupled to alarm circuit 200 via line 216 and to status display 56 via line 218.
  • Reset switch 76 is coupled to alarm circuit 200 via line 219 and to mode circuit 220 via line 221.
  • Resume switch 156 is coupled to mode cir ⁇ cuit 220 via line 222 and mode switch 48 is coupled to mode circuit 220 via reinfuse signal line 224, irrigate signal line 225, collect signal line 226, bypass signal line 227, prime signal line 228, and load signal line 229.
  • mode circuit 220 The output of mode circuit 220 is connected to pump control circuit 230 via lines 231, 232.
  • Pump on/off switch 70, whole blood speed pump control 144 and recirculation pump control 146 are also connected to pump control circuit 230 via lines 233, 234 and 235, respectively.
  • Pump control circuit 230 is connected to motor control 236 and to motor control 238 via lines 239 and 240, respectively.
  • Fail-safe circuit 174 is connected to a fail-safe relay 242 via line 243, and fail-safe relay 242 is connected to motor control 236 and 238 via lines 244 and 245, respectively.
  • the plasma scale circuit 188 is connected to mode circuit 220 via line 246.
  • Line 246 also couples the plasma scale circuit to mute circuit 248, the output of which is coupled to an audible alarm 250. When mute switch 72 is actuated, the audible alarm will be deactivated.
  • Alarm circuit 200 is coupled to the mute cir- cuit 248 via line 252.
  • the hemodetector circuit is coupled to the mute circuit via line 253.
  • the mode circuit 220 is connected to the status display via line 254.
  • Clamp switch 50 is connected to status display 56 via line 255 and to fail-safe circuit 174 via line 256.
  • the fail-safe relay 242 is con ⁇ nected to clamp magnet 50'via line 258 and mode circuit 220 is connected to clamp circuit 260 via line 261, with the clamp circuit 260 outputting to the status display 56 via line 262 and to clamp magnet 50'via line 263.
  • mode circuit 220 which is schematically illustrated in FIGURES lla-llb (con- nected together) will now be described.
  • mode signal lines 224-229 from rotary mode switch 48 are fed via re ⁇ sistors 270-275, respectively, and inverters 276- 281, respectively, to seven of the eight inputs of a 1 of 8 priority encoder 284.
  • the output 286 of an AND gate 288 is connected to the highest priority input of the priority encoder 284.
  • the load signal line is fed via line 290 to an input of AND fate 288 and the collection complete signal line is fed via line 292 to the other input of AND gate 288.
  • Priority encoder 284 provides a binary output via lines 294, 295 and 296, which are fed through amplifiers 298, 299 and 300, respectively, to the binary inputs of a PROM 304.
  • the load signal on line 229 has the lowest pri ⁇ ority
  • the unload signal C which is the combin ⁇ ation of the collection complete signal on line 292 and the load signal on line 290
  • Encoder 284 takes the highest priority input line and outputs the highest level. In this manner, the various modes are given status levels, in the following order (starting with the lowest status): load, prime, by ⁇ pass, collect, collection complete, irrigate, reinfuse and unload.
  • PROM 304 could be a ROM if desired.
  • the output of PROM 304 is held by latch 306, which is clocked every second so that the output of PROM 304 is loaded into latch 306 via lines 307-310 every second.
  • the output of latch 306 is fed back to the input of PROM 304 via lines 312-315.
  • Lines 312-215 also feed the output of latch 306 to inputs of a comparator 320.
  • Comparator 320 compares the binary signal at the input of PROM 304 with a binary signal that is being fed back via lines 312-215. If those binary signals are not equal to each other, an incorrect mode is indicated and the machine is shut off.
  • Output 322 of encoder 284 senses all of the inputs and if there is no signal from any of the inputs, this would signify that dial switch 48 is between mode positions.
  • a signal is fed to OR gate 324 via line 325 and this signal is OR'd with an output signal from comparator 320 fed on line 326.
  • OR gate output line 328 to energize a lamp on display 56 which will read "mode switch", as stated above.
  • PROM 304 is preferably a 256 x 4 PROM which allows 256 possible combinations with respect to the inputs.
  • the outputs from latch 306 are connected to a second PROM 330 via lines 331-334.
  • PROM 330 is a 32 x 8 PROM and the eight outputs of PROM 330 feed enable signals via lines 336-343.
  • the signal on line 336 is an anticoagulant pump enable signal
  • the signal on line 337 is a whole blood pump enable signal
  • the signal on line 338 is a hemolysis detector enable signal
  • the signal on line 339 is a bubble detector enable signal
  • the signal on line 340 is a tare/measure select signal
  • the signal on line 341 is a clamp ' magnet enable signal
  • the signal on line 342 is an occluded vein sensor enable signal
  • the signal on line 343 is a whole blood pump total volume counter enable signal.
  • PROM 304 is the PROM (or ROM) which programs whether the particular mode is correct.
  • the second PROM (or ROM) 330 is programmed to determine what should be done when the system is in a valid mode. In other words, if PROM 304 determines that the system is in a proper mode, PROM 330 will determine what should happen as a result of the proper mode (e.g., the enable signals that should be provided) . Thus the output signals on lines 336-343 do not actually ener ⁇ gize the pumps and other items, but they are enabling signals.
  • the output of second PROM 330 will enable the pumps. This will allow the operator to turn the pumps on manually by depressing the pump start switch 70.
  • Line 328 is connected to line 350 which represents an incorrect mode signal.
  • Line 328 is also connected through inverter 351 and inverter 352 to the mode ' switch lamp in display 56.
  • the operator can turn the dial switch 48 to the mode in which he wants to op rate, press the resume switch and the ROM 304 will be overridden so that the particular mode selected will be operating.
  • This resume operation may be useful if the wrong mode has been selected, but it is important that the operator return to the right mode as soon as possible.
  • the pump start circuit is illustrated in FIGURE 12. Referring to FIGURE 12, it is seen that anti ⁇ coagulant pump enable signal line 336 from PROM 330 is fed to an input of AND gate 360. Whole blood pump enable signal line 337 is fed to an input of
  • NAND gate 362 A system armed signal from the clamp (indicating that the clamp is in its undamped position) is fed via line 364 to the other input of NAND gate 362. If the tubing clamp is undamped, a system armed signal will' be provided on line.364 and if at the same time a pump enable signal is provided via line 337, the output of NAND gate 362, which is connected to the reset input of flip-flop 366, will indicate that flip-flop 366 should not reset. When flip-flop 366 is reset, Q output 367 is 0 and since output 367 is connected to an input of AND gate 360, output line 368 of AND gate 360 will be low so that the anticoagulant pump is off.
  • Q output 367 is also connected through an inverter 372 and a resistor 373 to a pump switch signal lamp, preferably in the form of an LED. Q output 367 is also fed via amplifier 374 to turn on the whole blood pump.
  • AND gate 360 is coupled to output 367 while the other input of AND gate 360 is coupled to the "ACD pump enable" signal, from line 336.
  • the anticoagulant pump will be turned on only if both signals from the "whole blood pump on" line 460 and from the "anticoagulant pump enable" line 336 are high.
  • the mute circuit diagram of FIGURE 13 shows the system for turning off the alarm sound only with respect to the particular alarm condition that is occurring. In other words, if there is an abnormal condition and the alarm sounds, the alarm can be muted so that it no longer sounds.
  • the mute switch is coupled via line 400, resistor 402, inverter 404 and clock 406 to the clock input of shift register 408.
  • the alarm signal is fed via line 410 to an input 450 of shift register 408 and the collect plasma signal is fed via line 412 to an AND gate 414.
  • the other input of the AND gate 414 is connected via line 416 to line 227 which carries the bypass mode signal.
  • the output of AND gate 414 is connected to another input 456 of the shift register 408.
  • An anticipation collection complete signal is fed via line 420 through resistor 421 and inverter 422 to another input 452 of shift register 408 and via line 423 to an input of NAND gate 424.
  • a collection com ⁇ plete signal is fed via line 426 through resistor 427 and amplifier 428 and via line 429 to another input 454 of shift register 408 and to an input of AND gate 430.
  • the output of AND gate 414 is connected via line 432 to an input of AND gate 434 and the signal on line 410 is connected via line 436 to an input of NAND gate 438.
  • the other inputs of NAND gates 438, 424, 430 and 434 are coupled to outputs of the shift register 408.
  • NAND gates 424, 430 and 434 are connected to inputs of another NAND gate 440, the output of which is connected via line 441 to a NAND gate 442.
  • the output of NAND gate 442 is connected to an input of NAND gate 443, the output of which provides an audible alarm signal.
  • the output of NAND gate 438 is connected directly to the other input of NAND gate 443.
  • the mute signal on line 400 will actually be a not mute signal, indicating that the mute switch has not been energized.
  • shift register 408 The outputs of shift register 408 are fed to inputs of NAND gates 438, 424, 430 and 434 and once reset, shift register 408 outputs provide a high signal at each of the respective inputs to the NAND gates.
  • the other inputs to the NAND gates are the signals from the various alarm conditions, as previously indicated. Thus if one of those signals from an alarm condition also reaches the NAND gate after the shift register has been reset, there will be an audible alarm as indicated in the mute circuit diagram.
  • the mute switch operates to invert whatever signal is on the input lines and then transfer that signal to the output lines. For example, if shift register 408 was reset so that the outputs were all high's and if the inputs were all low's, if the mute switch was pressed the outputs would be the inverse of the inputs. Thus the mute switch also operates to make the re ⁇ spective output the inverse of its input. If input 450 of shift register 408 had a high signal which indicated an alarm, output 451 of shift register 408 would be low. Likewise, if input 452 was low, then output 453 would be high if the mute switch were pressed. The effect is that if an alarm condition exists and the mute switch is pressed, the particular alarm for the particular alarm condition will be shut off.
  • the mute switch operates only for the particular signals that are at the .shift register at the moment that the mute switch is pressed. If after the mute switch is pressed input 454 has a high signal, output 455 will remain high and both inputs of the respective NAND gate 430 will have high signals so that there will be an audible alarm. If the shift register 408 is reset so that all of the outputs 451, 453, 455 and 457 are high, and there is an alarm signal at input 450 and an alarm signal at input 456, normally there would be an audible alarm. However, if the operator wishes to obviate the audible alarm, the mute switch is pressed and output 451 and output 457 have low signals, thereby muting the audible alarm. On the other hand, the alarm would not be muted for alarm signals at input 452 and input 454.
  • the pump circuit is not started unless there is both a "pump enable" signal on line 337 and a "system armed” signal on line 364.
  • an RC circuit is utilized in a manner so that there is less current to the pump motor while a capacitor is being charged.
  • the* pump motor speed is controlled only by the motor speed control potentiometer which is manually controlled by knobs 144 and 146 (FIGURES 1 and 2) .
  • the purpose of the initial slow speed with respect to the whole blood pump is to prevent the occlusion of a vein that might result if the blood was drawn rapidly from the beginn ng.
  • the pump motor control circuit is illustrated in FIGURE 14.
  • An identical pump motor control is utilized for controlling the whole blood pump and the recirculation pump.
  • the pump on/off signal is fed via line 460 through resistor 461 to the base of a transistor 462.
  • the "on" signal is the high while the "off” signal is a low.
  • transistor 462 When the "on" signal is provided on line 460, transistor 462 will become more conductive and an LED 464, connected in series with the collector of transistor 462, will be energized to provide a more positive voltage at the base of an optically isolated NPN transistor 466.
  • LED 464 and NPN transistor 466 comprise a single unit forming an optical isolator. Once the optical isolator is energized, the voltage is placed across the RC circuit comprising resistor 468 and capacitor 470 so capacitor 470 will charge. At the RC junction 472 there is a diode 474 which is coupled to an input 475 of an operational amplifier 476.
  • a potentiomenter 482 is connected to the col ⁇ lector of transistor 466 and input 475 of amplifier
  • potentiometer 482 is connected through resistor 484 to the wiper arm of potentiometer 482.
  • potentiometer 482 forms the whole blood pump speed control which is operated by manually turning knob 144.
  • the negative input 485 of amplifier 4-76 is connected to the emitter 478 via line 486.
  • the alarm circuit is schematically illustrated in FIGURE 15. During the operation of the apparatus, certain of the functions are enabled at certain times while others are not enabled at these times. For example, during the "prime” mode, the bubble detector is not enabled because there are bubbles during "prime” and it would present an alarm if the bubble detector were enabled.
  • FIGURE 15 the lines carrying signals for various functions are illustrated and it can be seen that some of the functions, such as the bubble detector, occluded vein sensor and the hemolysis detector, require enable and operational signals for a malfunction signal to be fed to latch 500.
  • operational signals and enable signals are fed to the inputs of NAND gates 502, 504 and 506, the outputs of which represent, respectively, the bubble detector signal, the occluded vein detector signal and the hemolysis detector signal being fed to latch 500.
  • latch 500 is an RS latch (reset-set latch) and the function signals are fed to the reset inputs.
  • the reset inputs predominate. If a reset signal is fed to the set input 513 of the lat.ch, because the reset input predominates, the functions will predominate notwith- standing the reset signal at the set input. As long as the condition is present, even if a reset signal is presented at the set input 513 of the latch 500, the latch will not reset.
  • gates 502, 504 and 506 are NAND gates, and since inverters 508, 510 and 512 are used, the signals that will be fed, to latch 500 if there is a malfunc ⁇ tion will be low signals.' . Any output from the latch is an alarm signal which shuts down the system and provides audible and lamp signals.
  • a sensor override switch 74 allows the operator to override some of the alarm signals. Switch 74 is connected to a latch 520 which is coupled to an input of NAND gate 522. Reset switch 76 is also coupled to latch 520 and to the set input of latch 500.
  • Outputs 524, 525 and 526 of latch 500 are coupled to the inputs of NAND gate 528 and outputs 529, 530 and 531 of latch 500 are coupled to the inputs of NAND gate 532.
  • the output of NAND gate 528 is connected to an input of NAND gate 522, the output of which is connected to an input of NAND gate 532.
  • the output of NAND gate 532 is connected to the audible alarm system.
  • NAND gate 528 which is one of the inputs of NAND gate 522, the other of which comes from latch 520 which is controlled by the sensor override switch.
  • the alarm for the occluded vein sensor, hemoly-gis detector and pressure sensor can be overridden.
  • the clamp circuit of the present invention is schematically illustrated in FIGURE 16.
  • clamp switch 50 is connected through an inverter 540 to "return clamped" lamp 542 via line 255.
  • "return clamped” lamp 542 is one of the lamps within display 56.
  • Clamp switch 50 is also connected to an input of AND gate 544 via line .545.
  • Other inputs to the AND gate 544 include an incorrect mode signal which is fed through inverter 546 and via line 547 to the AND gate 544, magnet enable signal which is fed via line 548 to an input of AND gate 544 and a reset signal which is fed through inverter 549 and via line 550 to an input of AND gate 544.
  • the output of AND gate 544 is coupled through resistor 552 to the base of PNP transistor 554, the emitter of which is grounded and the collector of which is connected to the clamp magnet 50'.
  • Clamp magnet 50' comprises a coil 50a and diode 50b, with an appro ⁇ priate voltage source coupled thereto.
  • the output of AND gate 544 is also connected via line 556, inverter 557 and line 262 to "system armed" lamp 558 which, as illustrated in FIGURE l ⁇ £, forms a portion of the status display 56.
  • AND gate 544 receives the clamp switch signal in addition to an in ⁇ correct mode signal which is inverted so it actually becomes a correct mode signal. When all of the signals are present, there will be an output signal from AND gate 544 to turn on transistor 554 so that the clamp magnet 50' will be energized. At the same time, the system armed lamp 558 will become energized.
  • a fail-safe circuit is provided in order to shut off the system if there is a serious malfunction.
  • the fail-safe circuit is in addition to the alarm cir ⁇ cuit and is responsive to the pump speed tachometers, the tubing clamp, the bubble detector and an emergency stop switch (i.e., panic button).
  • the fail ⁇ safe circuit includes whole blood pump tachometer sig ⁇ nal line 175 and recirculation pump tachometer signal line 178, each of which feeds through a resistor 560, 561 and an inverter 562, 563 to a counter 564, 565 respectively.
  • the reset inputs of counters 564, 565 are clocked by means of a clock 566 which is coupled 'through a capacitor 567 and a parallel circuit in ⁇ cluding resistor 568 and diode 569.
  • the output of counter 564 is fed via line 570 to an input of OR gate 571 while the output of counter 565 is fed via line 572 to another input of OR gate 571.
  • the clamp signal is fed via line 256 through resistor 574 to an input of OR gate 576.
  • the bubble detector enable signal is fed via line 208 through resistor 573 and inverter 579 to another input of OR gate 576.
  • a second or safety bubble detector signal is fed via line 580 through resistor 581 and inverter 582 to another input of OR gate 576.
  • the output of OR gate 576 is fed to a shift register 584. If there are any inputs at OR gate 576, the output will reset the shift register 584 to provide a zero or low signal via line 585 to OR gate 571.
  • Counters 564 and 565 are clocked so that if the amount of pulses on- either line 175 or line 178 from the tachometer exceeds the count in one second from counter 564 or counter 565, there will be a high signal from one of these counters to OR gate 571. A high signal will then be fed to NOR gate 586 which is coupled with NOR gate 588 as illustrated to form a latch. When NOR gates 586 and 528 latch, a low signal provided through resistor 590 to the base of transistor 592 will provide a relay off signal along line 593 to shut off the entire system.
  • shift register 584 will provide a high signal to OR gate 571 thereby providing a signal to latch 586, 588 and the system will shut off in the manner set forth above.
  • clock 566 provides a one second clock signal and counters 564 and 565 are read every second. If there are more counts going into the counter than its setting, an output signal is provided.
  • counter 564 is programmed to provide an output signal if the tachometer shows that there.is a flow of more than 150 ml per minute. If the tubing has a predetermined diameter, the flow rate is directly proportional to the speed of the tachometer and thus the flow rate can be determined by the tachometer out ⁇ put pulses.
  • counter 565 provides an output signal if there is a flow rate of greater than 600 ml per minute.
  • the outputs of counters 564 and 565 represent 2 to the 12th power and the calibration is such that 2 to the 12th power with counter 564 represents 150 ml per minute while 2 to the 12th power with counter 565 is equivalent to 600 ml per minute.
  • the blood is usually flowing from the donor at up to 100 ml per minute and is recirculated to the donor at approximately 300 ml per minute.
  • Shift register 584 serves to pro ⁇ vide a four second delay.
  • condition at the output of OR gate 576 to the reset input of shift register 584 has to be in the low condition for more than four seconds for shift register 584 to provide a high output signal which is inputted to OR gate 571. This delay is needed to prevent nuisance problems from latching the fail-safe circuit.
  • NOR gates 586 and 588 latch, signals are provided via line 596 and through resistors 597 and 598, transistors 599 and 600, to a "fail-safe" lamp via line 601 and to an audible alarm device via line 602.
  • the fail-safe lamp is part of the alarm system of display 58.
  • a "power on” reset circuit including a PNP transistor 604 having resistor 605 in its base- emitter circuit and capacitor 606 in its base-col- lector circuit.
  • the latch 586, 588 When the system is initially turned on, the latch 586, 588 is set in an armed mode. When the latch is armed, any of the events which provide an output from OR gate 571 acts to set the latch by feeding a high signal to NOR gate 586 via line 608.
  • the relay coupled to line 593 is normally ener- gized if conditions are satisfactory. If there is a disable, the relay is deenergized.
  • the relays are shown in FIGURE 18 which is a block diagram of the fail-safe circuit.
  • the primary power plug 610 is coupled to a suitable source of alternating current and various power supplies and circuits are connected across the alternating current lines 611 and 612.
  • a DC power supply 613 for the logic circuitry is connected in the AC circuit as is the DC power supply 614 for the lamps and fail-safe circuit.
  • whole blood pump motor control circuit 616 and recirculation pump motor control 618 are coupled across the AC lines.
  • a first circuit breaker power switch 620 ganged to circuit breaker switch 621 is utilized to open the AC lines.
  • relay 622 having ganged con ⁇ tacts 623, 624 and 625 is operable in response to the fail-safe circuit of FIGURE 17.
  • contacts 620, 621 are open, current to the entire system ceases and the apparatus is completely shut off.
  • the opening of contact 624 will deenergize relay 626 to open contact 627 and 628 which provide the alternating current for an auxiliary anticoagulant pump. Opening of contacts . 624 will also deenergize clamp magnet 50'.
  • relay 622 effectively oper- ates off its own DC voltage circuit. Once relay 622 operates to open the line, power to both pumps will be turned off, power to the clamp will be turned off and relay 626 will be deenergized to turn off the auxiliary anticoagulant pump. Thus if critical problems occur, such as air bubbles are detected or the motor speed increases past a fixed amount, all essential operations of the system will be automatically shut off by the fail-safe circuit.
EP19810901222 1980-04-14 1981-03-17 Dispositif de fractionnement du sang. Withdrawn EP0050146A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14011180A 1980-04-14 1980-04-14
US140111 1980-04-14

Publications (2)

Publication Number Publication Date
EP0050146A1 EP0050146A1 (fr) 1982-04-28
EP0050146A4 true EP0050146A4 (fr) 1982-12-09

Family

ID=22489809

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19810901222 Withdrawn EP0050146A4 (fr) 1980-04-14 1981-03-17 Dispositif de fractionnement du sang.

Country Status (9)

Country Link
EP (1) EP0050146A4 (fr)
JP (1) JPS57500633A (fr)
BE (1) BE888391A (fr)
BR (1) BR8108309A (fr)
CA (1) CA1155098A (fr)
ES (1) ES501371A0 (fr)
IT (1) IT1137541B (fr)
WO (1) WO1981002979A1 (fr)
ZA (1) ZA812369B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501531A (en) * 1981-12-15 1985-02-26 Baxter Travenol Laboratories, Inc. Control circuit for a blood fractionation apparatus
FR2519555A1 (fr) * 1982-01-11 1983-07-18 Rhone Poulenc Sa Appareillage et procede de plasmapherese alternative avec appareil a membrane
EP0087964A1 (fr) * 1982-03-01 1983-09-07 Baxter Travenol Laboratories, Inc. Système de courant de fluide et isolateur/intégrateur associé à un transducteur de pression
US4493693A (en) * 1982-07-30 1985-01-15 Baxter Travenol Laboratories, Inc. Trans-membrane pressure monitoring system
SE451056B (sv) * 1982-09-10 1987-08-31 Gambro Lundia Ab Slangset avsett for extrakorporeal behandling av blod och liknande omtaliga vetskor
US4464164A (en) * 1982-09-24 1984-08-07 Extracorporeal Medical Specialties, Inc. Flowrate control for a blood flow system
US5034135A (en) * 1982-12-13 1991-07-23 William F. McLaughlin Blood fractionation system and method
ATE89178T1 (de) * 1982-12-13 1993-05-15 Mclaughlin William F Blutfraktionierungssystem.
CA1258053A (fr) * 1982-12-13 1989-08-01 Halbert Fischel Systeme et methode pour le fractionnement du sang
FR2548541B1 (fr) * 1983-07-07 1986-09-12 Rhone Poulenc Sa Procede de plasmapherese et appareillage utilisable notamment pour ce procede
JPS6145772A (ja) * 1984-08-07 1986-03-05 テルモ株式会社 血漿分離装置
US4850998A (en) * 1987-10-07 1989-07-25 Baxter International Inc. Method for wetting a plasmapheresis filter with anticoagulant
IT1242940B (it) * 1990-12-07 1994-05-18 Sifra S P A Impianto ad alto rendimento per la attuazione di emodialisi, emofiltrazione plasmaferesi, emodiafiltrazione
IT1310933B1 (it) * 1999-11-16 2002-02-27 Luigi Benatti Macchina multifunzionale per il monitoraggio ed il controllo diterapie locoregionali in oncologia.
US6863821B2 (en) 2002-02-02 2005-03-08 Baxter International Inc. Shear-enhanced systems and methods for removing waste materials and liquid from the blood
US8182440B2 (en) * 2002-09-27 2012-05-22 Baxter International Inc. Dialysis machine having combination display and handle
US8961789B2 (en) 2008-10-31 2015-02-24 Baxter International Inc. Systems and methods for performing hemodialysis
US9833557B2 (en) * 2014-12-19 2017-12-05 Fenwal, Inc. Systems and methods for determining free plasma hemoglobin
US11139074B2 (en) 2016-03-14 2021-10-05 Fenwal, Inc. Cell washing system with process parameter control
EP3940706A1 (fr) 2016-05-27 2022-01-19 Fenwal, Inc. Système de traitement de cellules et procédé doté d'un processus d'évaluation préliminaire
US10654000B2 (en) 2016-07-13 2020-05-19 Fenwal, Inc. Cell processing system and method with centralized data management, monitoring and/or control

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1122526A (en) * 1966-03-03 1968-08-07 Gambro Ab A dialysis device for purifying blood or other liquids
US3648694A (en) * 1968-09-25 1972-03-14 Inst Oncologic Bucharest Automatic system with perfusion protection against malfunction
US3946731A (en) * 1971-01-20 1976-03-30 Lichtenstein Eric Stefan Apparatus for extracorporeal treatment of blood
JPS52155888A (en) * 1976-06-22 1977-12-24 Mitsui Toatsu Chemicals Device for continuously removing material in blood flow
US4086924A (en) * 1976-10-06 1978-05-02 Haemonetics Corporation Plasmapheresis apparatus
SU599310A1 (ru) * 1976-10-25 1978-03-25 Отдел Энергетической Кибернетики Ан Молдавской Сср Устройство дл регулировани фазового сдвига между двум трехфазными системами напр жений
US4111198A (en) * 1977-06-02 1978-09-05 Alvin J. Marx Automated intravenous fluid regulating and administering apparatus
US4185629A (en) * 1977-10-18 1980-01-29 Baxter Travenol Laboratories, Inc. Method and apparatus for processing blood
US4210138A (en) * 1977-12-02 1980-07-01 Baxter Travenol Laboratories, Inc. Metering apparatus for a fluid infusion system with flow control station
US4227526A (en) * 1978-04-13 1980-10-14 Extracorporeal Medical Systems, Inc. Mechanism for aurally instructing a patient and method
WO1979001121A1 (fr) * 1978-05-25 1979-12-27 Department Of Commerce Procede de separation de suspensions liquides contenant des globules sanguins par filtration

Also Published As

Publication number Publication date
CA1155098A (fr) 1983-10-11
EP0050146A1 (fr) 1982-04-28
BR8108309A (pt) 1982-03-09
JPS57500633A (fr) 1982-04-15
IT1137541B (it) 1986-09-10
ES8206188A1 (es) 1982-08-16
ES501371A0 (es) 1982-08-16
ZA812369B (en) 1982-04-28
IT8121081A0 (it) 1981-04-10
WO1981002979A1 (fr) 1981-10-29
BE888391A (fr) 1981-07-31

Similar Documents

Publication Publication Date Title
WO1981002979A1 (fr) Dispositif de fractionnement du sang
US4379452A (en) Prepackaged, self-contained fluid circuit module
EP0348475B1 (fr) Procedes et appareil de generation d'un concentre de plaquettes
US4526515A (en) Fluid pumping assembly including a prepackaged fluid circuit module
US4501531A (en) Control circuit for a blood fractionation apparatus
US4447191A (en) Control circuit for a blood fractionation apparatus
US4637813A (en) Blood processing assembly including a prepackaged fluid circuit module
EP0128683B1 (fr) Système de fractionnement du sang utilisant une aiguille unique ayant une recirculation réglable à travers un filtre
CA2064712C (fr) Methode et appareil d'administration d'un anticoagulant a une suspension de globules rouges d'un separateur de sang
EP0181732B1 (fr) Appareil automatisé pour l'irradiation de parties du sang
US4582598A (en) Replacement fluid control system for a blood fractionation apparatus and the like
EP1208856B1 (fr) Appareil pour la collecte de plaquettes sanguines
JPH0910299A (ja) 自動輸血装置
EP0156496B1 (fr) Appareil pour le traitement du plasma
EP0784496A1 (fr) Systemes et procedes de separation des erythrocytes
JPH0475016B2 (fr)
EP0228160B1 (fr) Dispositif de filtrage de plasma du sang
CN108601880A (zh) 用于控制便携式透析系统中的静脉空气回收的系统和方法
US5358482A (en) Single-needle extracorporeal plasmapheresis circuit
CA1140017A (fr) Dispositif de gardiennage d'un circuit de traitement de fluides
AU7172181A (en) Blood fractionation apparatus
JPH0117704B2 (fr)
US4678458A (en) Method for avoiding mistakes during plasmapheresis
JPH0651057B2 (ja) 血液処理装置
WO1992020383A1 (fr) Systeme pour separer les constituants du sang

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19811202

AK Designated contracting states

Designated state(s): DE FR GB SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19841012

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BILSTAD, ARNOLD A.

Inventor name: BROWN, RICHARD I.

Inventor name: FOLEY, JOHN T.